
BBI
Healthcare · Biotechnology & Medical Research · $6.8M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2022
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 9, 2024 | Time not confirmed | -1.69 | 0.00 | +100.0% |
| Mar 20, 2024 | Time not confirmed | -1.51 | -0.21 | +86.3% |
| Nov 13, 2023 | Time not confirmed | -0.60 | 0.32 | +153.3% |
| Aug 11, 2023 | Time not confirmed | -1.68 | -0.39 | +76.8% |
| May 10, 2023 | Time not confirmed | -1.65 | -1.14 | +30.9% |
| Mar 30, 2023 | Time not confirmed | -1.43 | -1.50 | -4.9% |
| Nov 10, 2022 | Time not confirmed | -1.43 | -2.07 | -44.8% |
| Aug 11, 2022 | After the close | -1.44 | -0.01 | +99.3% |
| May 12, 2022 | After the close | -2.59 | -3.60 | -39.0% |
| Mar 15, 2022 | Before the open | -3.82 | -2.70 | +29.3% |
| Nov 9, 2021 | After the close | -5.62 | -7.20 | -28.1% |
| Aug 12, 2021 | After the close | -5.62 | -7.20 | -28.1% |
| May 13, 2021 | After the close | -5.17 |
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the…
| -6.75 |
| -30.6% |
| Mar 9, 2021 | After the close | -4.05 | -6.75 | -66.7% |
| Nov 12, 2020 | After the close | -8.32 | -6.75 | +18.9% |
| Aug 12, 2020 | After the close | -0.43 | -0.43 | 0.0% |
| May 13, 2020 | After the close | — | -1.37 | — |
| Mar 18, 2020 | After the close | -0.13 | -1.37 | -953.8% |
| Nov 13, 2019 | After the close | -0.49 | -1.65 | -236.7% |
| Jul 12, 2019 | Before the open | -0.77 | -0.77 | 0.0% |
| May 2, 2019 | After the close | -1.26 | -1.47 | -16.7% |
| Feb 19, 2019 | After the close | -1.19 | -1.19 | 0.0% |
| Oct 29, 2018 | Before the open | -1.54 | -0.49 | +68.2% |
| Aug 7, 2018 | Before the open | -1.89 | -1.54 | +18.5% |
| May 3, 2018 | Before the open | -0.63 | -2.03 | -222.2% |
| Mar 15, 2018 | Before the open | -0.73 | -1.47 | -101.4% |